<![CDATA[Novo Nordisk A/S - Press Releases]]><![CDATA[Novo Nordisk employee suspended after being charged with insider trading]]><![CDATA[Clinical study shows liraglutide reduced blood sugar, weight and blood pressure in patients with type 2 diabetes]]><![CDATA[Over 70% of patients reach target with NovoMix® 30 in largest ever diabetes study]]><![CDATA[New data from head-to-head study confirms once-daily Levemir® is as effective as glargine over a 24-hour period in subjects with type 2 diabetes]]><![CDATA[Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128 (long-acting factor VIIa)]]><![CDATA[New studies show FlexPen® superiority to SoloStar® in dose accuracy]]><![CDATA[Novo Nordisk researchers nominated for Europe’s top innovation prize]]><![CDATA[Novo Nordisk donation aids Chinese pharmaceutical development and WHO efforts to combat neglected diseases]]><![CDATA[Novo Nordisk wins design award for NovoFine® Autocover®]]><![CDATA[TransTech Pharma, Inc. Acquires Three Programs for the Treatment of Metabolic Disorders from Novo Nordisk]]><![CDATA[Novo Nordisk licenses global rights to potential new haemostasis therapy]]><![CDATA[Discovery Health presents Diabetes: A Global Epidemic – a documentary on diabetes]]><![CDATA[Novo Nordisk celebrates first ever UN-observed World Diabetes Day]]><![CDATA[Novo Nordisk launches Changing Diabetes Barometer]]><![CDATA[Novo Nordisk celebrates 75-year commitment to diabetes research]]><![CDATA[Novo Nordisk receives approval for Levemir® in Japan]]><![CDATA[New data shows that the unique Levemir® weight benefit continues after two years]]><![CDATA[New data confirms NovoMix® 30 is associated with significantly fewer night-time and major hypoglycaemic events than biphasic human insulin (BHI)]]><![CDATA[Novo Nordisk receives approval in the EU for use of NovoRapid® in elderly people]]><![CDATA[The impact of childhood diabetes can be reduced by early diagnosis, prevention and improved control]]>